Looks like you’re on the UK site. Choose another location to see content specific to your location
New micro-robots developed to address hard-to-treat illnesses
Scientists have developed a new form of miniature robot that could be used to diagnose and treat illness in hard-to-reach areas of the human body.
Created by Chinese University of Hong Kong in collaboration with the Universities of Edinburgh and Manchester, the robots are around the same size as a blood cell and can be guided magnetically to different sites.
These robots were produced by coating tiny algae with non-harmful, biocompatible magnetic particles, and can smoothly swim in biological fluids, such as dilute blood and gastric fluid. By adjusting the thickness of the coating, the time taken for the robots to function and biodegrade can be customised.
In early tests, it was shown that these devices could be tracked in tissue close to the skin's surface by imaging the algae's natural luminescence, and in deeper tissue with the use of magnetic resonance imaging.
One potential application involves the incorporation of antitumour compounds into the algae core, which can be released during degradation to selectively attack cancer cells while leaving healthy tissue unharmed.
Qi Zhou, of the University of Edinburgh's school of engineering, said: "A small-scale robot that can be remotely guided, is easily tracked and harmlessly biodegrades potentially overcomes many of the challenges faced by minimally invasive therapies."
With over 20 years of experience within the service engineering market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current service engineering roles we have available, you can search for the latest job roles, register your details, or contact the team today.
We have hundreds of jobs available across the Healthcare industry, find your perfect one now.
Stay informed
Receive the latest industry news, Tips and straight to your inbox.
- Share Article
- Share on Twitter
- Share on Facebook
- Share on LinkedIn
- Copy link Copied to clipboard